Working Hours

08045477632

Tirzepatide 12.5mg

Tirzepatide 12.5mg

20900.0 INR/Piece

Product Details:

  • Life Span 24 Months from Manufacturing Date
  • Brand Name Tirzepatide
  • Packaging Type Box
  • Pacakaging (Quantity Per Box) 1 Pen
  • Dosage Form Injection
  • Origin of Medicine Imported
  • Salt Composition Tirzepatide 12.5 mg
  • Click to View more
X

Tirzepatide 12.5mg Price And Quantity

  • 20900.0 INR/Piece
  • 100 Piece
  • Clear, colorless to slightly yellow solution
  • Approved for medical use as per local health authority guidelines
  • May include nausea, vomiting, decreased appetite, or injection site reactions
  • Yes
  • A10BK04
  • 24 Months
  • Not for use in patients with Type 1 diabetes or diabetic ketoacidosis
  • Dispose of the used pen as per local regulations for medical waste
  • Subcutaneous

Tirzepatide 12.5mg Product Specifications

  • 12.5 mg per administration, as directed by the physician
  • Injection
  • Type 2 Diabetes Management
  • Administer subcutaneously once weekly or as prescribed
  • Box
  • 1 Pen
  • Tirzepatide
  • Adults
  • 24 Months from Manufacturing Date
  • 1 Pre-filled Pen
  • Indicated for glycemic control in adult patients with Type 2 diabetes mellitus
  • Antidiabetic
  • Tirzepatide 12.5 mg
  • Store at 2C to 8C (Refrigerate, do not freeze)
  • Imported
  • Tirzepatide
  • Injection
  • Blood Sugar Control, Weight Management
  • Clear, colorless to slightly yellow solution
  • Approved for medical use as per local health authority guidelines
  • May include nausea, vomiting, decreased appetite, or injection site reactions
  • Yes
  • A10BK04
  • 24 Months
  • Not for use in patients with Type 1 diabetes or diabetic ketoacidosis
  • Dispose of the used pen as per local regulations for medical waste
  • Subcutaneous

Tirzepatide 12.5mg Trade Information

  • Cash Advance (CA), Cash in Advance (CID)
  • 1000 Piece Per Week
  • 7 Days
  • No
  • Sample costs shipping and taxes has to be paid by the buyer
  • Middle East, Asia, Australia, Central America, North America, Eastern Europe, Western Europe, Africa, South America
  • All India

Product Description

Tirzepatide 12.5 mg Injection is a prescription-based pharmaceutical injectable used for chronic weight management and metabolic support in adults. It belongs to a new generation of therapies known as dual GLP-1 and GIP receptor agonists, designed to help regulate appetite, improve glycemic control, and support sustained weight reduction when combined with proper diet and lifestyle changes.

The 12.5 mg strength is typically part of an advanced dose-escalation regimen, prescribed after lower strengths such as 2.5 mg, 5 mg, 7.5 mg, or 10 mg, depending on patient tolerance and clinical response. This higher dosage is recommended for individuals requiring enhanced therapeutic outcomes under strict medical supervision.

Tirzepatide works by increasing satiety, reducing hunger signals, slowing gastric emptying, and enhancing insulin sensitivity, thereby helping patients manage calorie intake and achieve better metabolic balance.

The injection is usually administered once weekly via subcutaneous route and should only be used as directed by a qualified healthcare professional.


Key Features

  • Dual-action GLP-1 & GIP receptor agonist

  • Higher strength for advanced weight management therapy

  • Supports appetite control and metabolic regulation

  • Once-weekly subcutaneous injection

  • Part of step-up dosage treatment plans


Product Specifications

  • Strength: 12.5 mg

  • Dosage Form: Injection (Pre-filled pen / vial)

  • Administration: Subcutaneous

  • Category: Pharmaceutical Injectables

  • Storage: Refrigerated (2C 8C)

  • Prescription: Required (Rx Product)


SEO Keywords (Backend / Tags)

tirzepatide 12.5 mg injection, weight management injectable, anti obesity injection, GLP-1 GIP agonist injection, tirzepatide supplier india, prescription weight loss injection, tirzepatide dosage


Frequently Asked Questions (FAQs)

1. What is Tirzepatide 12.5 mg injection used for?

Tirzepatide 12.5 mg injection is used for weight management and metabolic control, especially in patients requiring higher therapeutic doses as prescribed by a doctor.


2. When is the 12.5 mg dose recommended?

The 12.5 mg dose is generally prescribed after gradual dose escalation, based on individual response and tolerance to lower doses.


3. How does Tirzepatide work?

It works by targeting GLP-1 and GIP receptors, helping reduce appetite, improve insulin response, and regulate food intake.


4. How is Tirzepatide administered?

It is administered as a once-weekly subcutaneous injection under medical supervision.


5. Is Tirzepatide 12.5 mg safe for weight loss?

It is a prescription-only medication and should only be used under the guidance of a qualified healthcare professional.


6. Do I need a prescription to buy Tirzepatide?

Yes, Tirzepatide injection is an Rx product and requires a valid prescription.


7. What are the storage conditions?

Store in a refrigerator at 2C to 8C, protected from heat and direct light.


8. What side effects may occur?

Some individuals may experience nausea, reduced appetite, or mild gastrointestinal discomfort. Consult a healthcare professional if symptoms persist.


9. Who should avoid using this injection?

It should not be used without proper medical consultation and is not suitable for individuals without a prescription.


Compliance Disclaimer

Disclaimer:
This product information is provided for educational purposes only. Tirzepatide is a prescription medication and should be used strictly under medical supervision.



Effective Glycemic Control and Weight Management

Tirzepatide 12.5mg offers dual benefits for adults with Type 2 diabetes: it not only assists in controlling high blood sugar levels but also aids in weight management. Used once weekly, as prescribed by your physician, this treatment is tailored to those seeking improved management of their diabetic condition. Its proven efficacy is anchored by regulatory approvals and international standards.


Simple and Safe Administration

This medication is administered subcutaneously, meaning an injection just beneath the skin, using a pre-filled pen. The process is straightforward-patients or caregivers should follow their doctor's guidance for injection sites and schedule. The clear, colorless to slightly yellow solution is designed for ease of use and optimal safety. Always keep the pen refrigerated and avoid freezing.


Comprehensive Safety and Storage Guidelines

Tirzepatide 12.5mg is intended only for adult patients with Type 2 diabetes. It is not suitable for those with Type 1 diabetes or diabetic ketoacidosis. Adverse effects can include gastrointestinal upset or localized reactions at the injection site, but these are generally manageable. Dispose of used pens as per local regulations for medical waste, and store unopened pens in a refrigerator at the recommended temperatures.

FAQ's of Tirzepatide 12.5mg:


Q: How should Tirzepatide 12.5mg be administered?

A: Tirzepatide 12.5mg is given as a subcutaneous injection, usually once a week, using the pre-filled pen provided. Follow your healthcare provider's instructions closely for correct administration and injection sites.

Q: What are the main benefits of using Tirzepatide 12.5mg?

A: This medication helps control blood sugar levels and supports weight management in adults with Type 2 diabetes. It is indicated as a part of a comprehensive diabetes treatment plan.

Q: When do I need to take Tirzepatide 12.5mg?

A: You should use Tirzepatide 12.5mg once weekly on the day and time directed by your physician. Maintaining a consistent schedule helps maximize the treatment's efficacy.

Q: Where should I store Tirzepatide 12.5mg pre-filled pens?

A: Store Tirzepatide pens in the refrigerator between 2C and 8C. Do not freeze the pen, and keep it in its original packaging until ready for use.

Q: What should I do after using the Tirzepatide 12.5mg injection pen?

A: Dispose of the used pen as per local guidelines for medical waste. Do not throw it in the household trash, and follow your healthcare provider's instructions for safe disposal.

Q: Who should not use Tirzepatide 12.5mg?

A: This medication is not suitable for individuals with Type 1 diabetes or those experiencing diabetic ketoacidosis. Always consult your doctor before beginning any new treatment.

Q: What adverse effects may be associated with Tirzepatide 12.5mg?

A: Some common adverse reactions include nausea, vomiting, decreased appetite, or mild irritation at the injection site. If you experience severe or persistent symptoms, inform your healthcare provider.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Weight Loss Injectables' category



Back to top